- CDC Eases COVID Social Distancing Guidance
- Race, Income Keeps Many Families From Letting Kids Play Sports
- Who Fares Worse After Multiple Sclerosis Strikes?
- Bioengineered Pig Skin Is Turned Into Corneas, Restoring Patients’ Sight
- AHA News: Health Conditions a Dentist Might Find That Have Nothing to Do With Your Teeth
- Vegetarian Women at Higher Odds for Hip Fracture
- When Removing a Big Kidney Stone, Get the Little Ones, Too
- Pandemic Showed Teachers’ Key Role in Spotting Child Abuse
- Health Highlights: Aug. 11, 2022
- Another Study Shows COVID’s Danger to Pregnant Women
Generic Aciphex Approved to Treat Chronic Heartburn

FRIDAY, Nov. 8The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said Friday.
Gastroesophageal reflux disease (GERD), also known as chronic heartburn, is a very common disorder characterized by backward flow of stomach acid to the esophagus. This process could damage tissue in the esophagus, the tube that connects the throat and stomach.
License to produce generic rabeprazole was granted to Dr. Reddy’s Laboratories, Kremers Urban Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals and Torrent Pharmaceuticals, the FDA said.
The drug is among a class called proton-pump inhibitors, which are designed to reduce the amount of stomach acid produced. Generic drugs, the FDA stressed, are equivalent to the brand-name versions in strength and quality.
More information
To learn more about GERD, visit Medline Plus.
Source: HealthDay